1. Home
  2. PAVS vs ADAG Comparison

PAVS vs ADAG Comparison

Compare PAVS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • ADAG
  • Stock Information
  • Founded
  • PAVS 2004
  • ADAG 2011
  • Country
  • PAVS United States
  • ADAG China
  • Employees
  • PAVS N/A
  • ADAG N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVS Health Care
  • ADAG Health Care
  • Exchange
  • PAVS Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • PAVS 90.2M
  • ADAG 81.9M
  • IPO Year
  • PAVS 2019
  • ADAG 2021
  • Fundamental
  • Price
  • PAVS $1.36
  • ADAG $1.91
  • Analyst Decision
  • PAVS
  • ADAG Strong Buy
  • Analyst Count
  • PAVS 0
  • ADAG 1
  • Target Price
  • PAVS N/A
  • ADAG $8.00
  • AVG Volume (30 Days)
  • PAVS 9.8K
  • ADAG 153.8K
  • Earning Date
  • PAVS 01-01-0001
  • ADAG 03-09-2025
  • Dividend Yield
  • PAVS N/A
  • ADAG N/A
  • EPS Growth
  • PAVS N/A
  • ADAG N/A
  • EPS
  • PAVS N/A
  • ADAG N/A
  • Revenue
  • PAVS $6,544,819.00
  • ADAG $815,746.00
  • Revenue This Year
  • PAVS N/A
  • ADAG N/A
  • Revenue Next Year
  • PAVS N/A
  • ADAG $2.70
  • P/E Ratio
  • PAVS N/A
  • ADAG N/A
  • Revenue Growth
  • PAVS N/A
  • ADAG N/A
  • 52 Week Low
  • PAVS $0.32
  • ADAG $1.64
  • 52 Week High
  • PAVS $2.48
  • ADAG $3.65
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 54.44
  • ADAG 53.99
  • Support Level
  • PAVS $1.32
  • ADAG $1.64
  • Resistance Level
  • PAVS $1.43
  • ADAG $1.95
  • Average True Range (ATR)
  • PAVS 0.05
  • ADAG 0.10
  • MACD
  • PAVS -0.01
  • ADAG 0.01
  • Stochastic Oscillator
  • PAVS 35.71
  • ADAG 87.10

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: